US Issues Recall of Shrimp Due to Radioactivity Concerns

U.S. health authorities have recalled shrimp imported from Indonesia due to potential contamination with radioactive cesium-137, emphasizing food safety concerns and the importance of monitoring imported seafood.
In an important public health update, U.S. authorities have announced the recall of certain frozen shrimp products over concerns related to potential radioactivity contamination. The recall implicates shrimp imported from Indonesia, specifically from a company named PT. Bahari Makmur Sejati. These products have been distributed across 13 states through retail giant Walmart.
The issue came to light after the detection of the radioactive isotope cesium-137 in some of the imported shrimp. While the levels of radioactivity found were minimal and posed no immediate health hazard, the Food and Drug Administration (FDA) emphasized the importance of caution. The agency clarified that none of the shrimp currently available in U.S. stores tested positive for radioactivity; however, the concern lies with the condition in which the shrimp was processed, packed, or stored.
Officials indicated that the shrimp may have been subjected to insanitary conditions that led to contamination, raising longer-term safety questions. Chronic exposure to low doses of cesium-137 has been associated with an increased risk of developing cancer over time.
In response, the FDA has urged Walmart to stage a recall and advised consumers who purchased the affected shrimp to dispose of it properly. Although the contamination levels are low, the recall underlines the importance of food safety monitoring in imported seafood.
This recall highlights the need for rigorous safety checks in the seafood supply chain and serves as a reminder for consumers to remain vigilant about the origins of their seafood products. For more details, visit source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Updated Guidelines for Diagnosing and Managing Heart Failure in Pregnancy and Postpartum
New guidelines from the Society for Maternal-Fetal Medicine highlight the importance of early diagnosis and multidisciplinary management of heart failure during pregnancy and postpartum to improve maternal and neonatal outcomes.
Overall Improvement in Cancer Outcomes in Australia
Australia has seen significant improvements in cancer survival and mortality rates over the past three decades, driven by advances in detection and treatment, with continued progress expected in future cancer research and data analysis.
Uncovering Hidden Genetic Risks in Hispanic/Latino Communities: Lessons from a Dominican Heart Mutation
A groundbreaking study reveals the presence of a critical heart-related genetic mutation among Dominican Americans, highlighting the importance of inclusive, ancestry-aware research in advancing precision medicine.
Revolutionary AI Tool Achieves 96% Accuracy in Assessing Fertilization-Competent Human Sperm
A novel AI model developed by the University of Hong Kong achieves over 96% accuracy in identifying human sperm capable of fertilization, promising to revolutionize fertility diagnostics and treatments worldwide.



